| Hepatocellular Carcinoma studied in …STUDIED_INderived200 of 3,122show all (up to 200) |
|---|
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05540925completed Vascular Invasion Prediction Via a Multimodal Model Supports Re-staging of Early-stage Hepatocellular Carcinoma · condition mapped ALIAS · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726161Phase 1/Phase 2 · recruiting Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227012Phase 1/Phase 2 · recruiting Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. · condition mapped ALIAS · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07305428NA · recruiting Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691762Phase 3 · not yet recruiting A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845266Phase 1 · completed Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GKL-006 Injection in Combination With TACE in Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04123379Phase 2 · active not recruiting Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084234Phase 4 · recruiting National Liver Cancer Screening Trial · condition mapped ALIAS · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618664Phase 3 · recruiting A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02) · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06737913Phase 2 · recruiting HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145141completed National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838415recruiting Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical Application of Immune Mechanisms in Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839767recruiting Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840092recruiting Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915753Phase 1 · recruiting Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07291076Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835737Phase 1/Phase 2 · not yet recruiting Safety and Efficacy of Folic Acid Combined With Atezolizumab and Bevacizumab as First-Line Therapy for Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836309not yet recruiting TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836530Phase 3 · not yet recruiting Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836712Phase 2 · not yet recruiting Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066138Phase 1 · recruiting A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06109272Phase 2/Phase 3 · active not recruiting A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858813Phase 1 · recruiting A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC) · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07596134NA · not yet recruiting Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005740Phase 1 · active not recruiting A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06040099Phase 2 · active not recruiting A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06929845NA · recruiting Organoid Models of Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07639138Phase 2 · recruiting Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793695Phase 2 · recruiting Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829926Phase 2 · not yet recruiting Lenvatinib Plus Tislelizumab With or Without Gefitinib for Advanced Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832006Phase 2 · recruiting Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954116Phase 2 · recruiting Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07627191early Phase 1 · recruiting GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827807Phase 2 · not yet recruiting PEARL Trial: Partial TACE Enhancing Anti-tumor Response With Lenvatinib in Unresectable HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02851784Phase 2/Phase 3 · recruiting Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07027436Phase 3 · recruiting Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma. · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824583NA · recruiting A Study Evaluating a New Radiation Treatment Workflow (NGDS) · condition mapped ALIAS · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824765not yet recruiting Heterogeneity of Treatment Effects of Adding Locoregional Therapies to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma (ISMIO-026) · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07825519NA · active not recruiting Effectiveness of Enhanced Web-Based Health Education on Self-Care Practices and Quality of Life Among Patients With Hepatocellular Carcinoma Undergoing TACE · condition mapped PROBABILISTIC · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460080completed Diagnostic Value of AFP-L3 and PIVKA-II in HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427941Phase 1/Phase 2 · recruiting A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823348Phase 3 · not yet recruiting JS207 Plus JS007 Versus Toripalimab Plus Bevacizumab as First-Line Treatment for Advanced Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05908786Phase 1/Phase 2 · terminated A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma · condition mapped ALIAS · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06007846Phase 2/Phase 3 · recruiting A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06968195Phase 1 · suspended Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07540832Phase 1/Phase 2 · not yet recruiting A Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776080Phase 2 · recruiting Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01300143Phase 2 · completed Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Childhood Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04380545Phase 1/Phase 2 · recruiting Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04721132Phase 2 · active not recruiting Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05883644Phase 3 · active not recruiting Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789198Phase 1 · recruiting Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA · condition mapped ALIAS · 3,122 trials mapped (929 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365839Phase 1 · withdrawn Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02772003Phase 1 · active not recruiting DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878550active not recruiting Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma · condition mapped ALIAS · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06309485Phase 2 · recruiting Phase 2 Study of WGI-0301 for Advanced HCC · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714538recruiting Breath Research Narrow Validation for Gastrointestinal Cancer Detection · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815054not yet recruiting Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With Surgical · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04864054Phase 1/Phase 2 · recruiting GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06563947Phase 2 · recruiting Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677774NA · recruiting GPC3-Targeted PET/CT in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07813572Phase 3 · not yet recruiting ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced Hepatocellular · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814014recruiting Real-world Insight Into Systemic Therapies for HCC: Single-center Study · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02968810Phase 2 · completed Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07272083recruiting New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03937830Phase 2 · active not recruiting Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07806292Phase 2 · recruiting Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526338Phase 2 · recruiting Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062055Phase 2 · recruiting BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109336NA · completed Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04246177Phase 3 · terminated Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06811116Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06921785Phase 3 · recruiting Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06999837NA · recruiting [68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling. · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07446257early Phase 1 · recruiting THIO and Cadonilimab in Resectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650773recruiting CHARM Hepatocellular Carcinoma MEA Study · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07801287Phase 2 · recruiting Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463248Phase 2 · recruiting PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07786792not yet recruiting Biomarker and Mechanism Study of Systemic Therapy in Unresectable HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07795437NA · recruiting GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05304481Phase 2 · recruiting Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06294548Phase 1/Phase 2 · recruiting A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06621472NA · recruiting Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07381660Phase 3 · recruiting SBRT Versus Surgical Resection for Small HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636148recruiting Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05497531NA · recruiting Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07669727not yet recruiting A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning. · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780357not yet recruiting HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03674073Phase 1 · completed A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06582017Phase 1 · recruiting Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07607769recruiting MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment. · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05063565Phase 2 · active not recruiting TheraSphere With Durvalumab and Tremelimumab for HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06187961Phase 2 · recruiting HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551778Phase 1/Phase 2 · not yet recruiting Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04039607Phase 3 · completed A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04510740active not recruiting Liver Cancer Registry Platform · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04601428early Phase 1 · terminated Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04770896Phase 3 · active not recruiting A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689175Phase 2 · recruiting Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05775159Phase 2 · active not recruiting Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084481Phase 1 · recruiting Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06620302Phase 1/Phase 2 · suspended Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Childhood Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781176NA · not yet recruiting Different Acupoint Stimulation for Postoperative Gastrointestinal Dysfunction in Primary Liver Cancer Patients · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07782632recruiting Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03655002Phase 1 · active not recruiting IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623369Phase 1 · recruiting A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05394259Phase 1 · active not recruiting A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06114082Phase 2 · completed TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06166576Phase 2 · recruiting Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06178198Phase 2 · recruiting Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06773845Phase 2 · recruiting Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07608458NA · not yet recruiting Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084884Phase 1/Phase 2 · active not recruiting A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636785Phase 1/Phase 2 · recruiting A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07774247Phase 2 · not yet recruiting Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05095519Phase 2 · completed Hepatocellular Carcinoma Imaging Using PSMA PET/CT · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05435014Phase 1/Phase 2 · terminated T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764316Phase 1 · recruiting A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06944483recruiting Same-day Radioembolization for Large HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06979219recruiting Streamlining Radioembolization for Small HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620574Phase 3 · enrolling by invitation Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07727759recruiting CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05791448Phase 1 · suspended AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06487559Phase 1 · active not recruiting A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07166406Phase 3 · recruiting Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07209813Phase 2 · recruiting GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768085NA · not yet recruiting Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03847428Phase 3 · active not recruiting Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221893NA · recruiting Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550481Phase 2 · active not recruiting Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764835not yet recruiting Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03782207completed A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701488Phase 1 · active not recruiting SIRT With Tremelimumab and Durvalumab for Resectable HCC · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618300active not recruiting Streamlined Resin Y90 Radiation Segmentectomy for Small HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06795022Phase 1/Phase 2 · recruiting First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04762888Phase 2 · completed 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965454Phase 2 · recruiting Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549829NA · recruiting the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07760012NA · recruiting 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07761286Phase 1/Phase 2 · not yet recruiting Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242470Phase 1 · recruiting A Study of MGC026 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06880523Phase 2 · recruiting STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06899152NA · recruiting HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904183Phase 2 · recruiting Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03859128Phase 2/Phase 3 · active not recruiting Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959800recruiting Molecular Basis of Pediatric Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06248554NA · completed Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07159048NA · recruiting The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07749859Phase 2 · not yet recruiting SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02519348Phase 2 · active not recruiting A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176483Phase 1 · recruiting Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910657Phase 1 · recruiting IDOV-Immune for Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07475026Phase 3 · recruiting A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07748481not yet recruiting Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and Surgical Resection for Subcapsular Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05168163Phase 2 · recruiting Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05199285Phase 2 · terminated A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07381634Phase 2 · recruiting The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745153completed Novel Abdominal Compression Positioning Technique for Respiratory Motion Management in Liver Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05443087NA · recruiting TARGETed Therapy Drug MONITOring in DIGestive Oncology · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06877637recruiting On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179900Phase 2 · recruiting Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03383458Phase 3 · active not recruiting A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175912Phase 2 · active not recruiting Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04912765Phase 2 · recruiting Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07268131NA · recruiting TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419841Phase 1 · recruiting A Phase 1 Study of the Safety and Tolerability of CTX-10726 · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04194775Phase 3 · active not recruiting A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03695250Phase 1/Phase 2 · terminated BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04712643Phase 3 · active not recruiting A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05621499NA · active not recruiting HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07732504NA · not yet recruiting AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07732686not yet recruiting Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07734857not yet recruiting Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06710223Phase 1 · active not recruiting Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059494Phase 4 · recruiting Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479485Phase 1/Phase 2 · recruiting MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03298451Phase 3 · active not recruiting Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07724951not yet recruiting The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07729592Phase 2 · not yet recruiting Dapagliflozin Add-on in Unresectable HCC With Metabolic Syndrome · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07729618NA · not yet recruiting AI-Guided First-Line Immunotherapy Selection in Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05117957Phase 2 · completed Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06193733Phase 2 · active not recruiting Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection - Phase II Clinical Trial · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06796114NA · recruiting Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07521852Phase 2 · recruiting A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04892810completed Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05208762Phase 1 · recruiting A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04930315Phase 2 · completed SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07690683NA · not yet recruiting Patients With Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07716345not yet recruiting Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05128032NA · completed Pressure-enabled Delivery in Radioembolization (TriNav Study) · condition mapped ONTOLOGY_EXACT · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05194293Phase 2 · active not recruiting Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer · condition mapped CURATED_BROADER · 3,122 trials mapped (929 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |